ICON EBITDA Margin 2010-2025 | ICLR

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for ICON (ICLR) over the last 10 years. The current EBITDA margin for ICON as of March 31, 2025 is .
ICON EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-03-31 $8.19B $1.47B 17.91%
2024-12-31 $8.28B $1.59B 19.15%
2024-09-30 $8.31B $1.61B 19.40%
2024-06-30 $8.33B $1.64B 19.67%
2024-03-31 $8.23B $1.62B 19.62%
2023-12-31 $8.12B $1.54B 18.99%
2023-09-30 $8.02B $1.48B 18.49%
2023-06-30 $7.90B $1.45B 18.33%
2023-03-31 $7.82B $1.42B 18.11%
2022-12-31 $7.74B $1.37B 17.65%
2022-09-30 $7.66B $1.30B 17.01%
2022-06-30 $7.59B $1.06B 14.02%
2022-03-31 $6.52B $0.87B 13.34%
2021-12-31 $5.48B $0.69B 12.66%
2021-09-30 $4.36B $0.55B 12.56%
2021-06-30 $3.19B $0.51B 16.05%
2021-03-31 $2.94B $0.47B 16.02%
2020-12-31 $2.80B $0.46B 16.37%
2020-09-30 $2.76B $0.46B 16.65%
2020-06-30 $2.77B $0.48B 17.40%
2020-03-31 $2.85B $0.52B 18.42%
2019-12-31 $2.81B $0.53B 18.75%
2019-09-30 $2.76B $0.50B 18.27%
2019-06-30 $2.70B $0.49B 17.97%
2019-03-31 $2.65B $0.46B 17.20%
2018-12-31 $2.60B $0.44B 16.95%
2018-09-30 $2.37B $0.43B 18.09%
2018-06-30 $2.16B $0.42B 19.24%
2018-03-31 $1.95B $0.41B 20.97%
2017-12-31 $1.76B $0.40B 22.70%
2017-09-30 $1.74B $0.39B 22.61%
2017-06-30 $1.72B $0.38B 22.35%
2017-03-31 $1.70B $0.38B 22.38%
2016-12-31 $1.67B $0.37B 22.26%
2016-09-30 $1.64B $0.36B 22.14%
2016-06-30 $1.61B $0.36B 22.11%
2016-03-31 $1.59B $0.35B 22.04%
2015-12-31 $1.58B $0.34B 21.59%
2015-09-30 $1.56B $0.32B 20.17%
2015-06-30 $1.56B $0.30B 19.42%
2015-03-31 $1.54B $0.28B 18.22%
2014-12-31 $1.50B $0.25B 16.89%
2014-09-30 $1.46B $0.23B 15.70%
2014-06-30 $1.41B $0.20B 14.25%
2014-03-31 $1.37B $0.18B 13.29%
2013-12-31 $1.44B $0.27B 18.71%
2013-09-30 $1.39B $0.26B 18.45%
2013-06-30 $1.34B $0.24B 18.15%
2013-03-31 $1.28B $0.23B 17.86%
2012-12-31 $1.21B $0.20B 16.67%
2012-09-30 $1.15B $0.19B 16.45%
2012-06-30 $1.10B $0.17B 15.31%
2012-03-31 $1.06B $0.17B 15.66%
2011-12-31 $1.02B $0.15B 15.05%
2011-09-30 $1.01B $0.26B 25.49%
2011-06-30 $1.00B $0.27B 27.41%
2011-03-31 $0.99B $0.28B 28.57%
2010-12-31 $0.99B $0.22B 21.90%
2010-09-30 $0.99B $0.14B 13.69%
2010-06-30 $0.98B $0.15B 15.09%
2010-03-31 $0.98B $0.15B 15.46%
2009-12-31 $0.89B $0.15B 16.80%
Sector Industry Market Cap Revenue
Medical Medical Services $10.336B $8.282B
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $132.070B 24.77
Elevance Health (ELV) United States $84.109B 10.85
CVS Health (CVS) United States $76.951B 9.56
Cencora (COR) United States $56.664B 19.71
DiDi Global (DIDIY) China $22.591B 34.29
Natera (NTRA) United States $20.935B 0.00
BioMerieux (BMXMF) France $15.355B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $12.529B 0.00
Solventum (SOLV) United States $12.251B 12.97
CochLear (CHEOY) Australia $11.298B 0.00
Revvity (RVTY) United States $10.529B 18.12
Viatris (VTRS) United States $9.730B 3.34
Doximity (DOCS) United States $9.525B 44.37
Avantor (AVTR) United States $8.647B 12.56
HealthEquity (HQY) United States $8.564B 42.13
Medpace Holdings (MEDP) United States $8.476B 22.51
Sonic Healthcare (SKHHY) Australia $8.176B 0.00
Charles River Laboratories (CRL) United States $6.716B 13.16
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
BrightSpring Health Services (BTSG) United States $4.048B 37.47
Bausch + Lomb (BLCO) Canada $3.990B 23.52
Sotera Health (SHC) United States $3.452B 19.61
Surgery Partners (SGRY) United States $2.922B 38.00
Alignment Healthcare (ALHC) United States $2.865B 0.00
Concentras Parent (CON) United States $2.710B 15.66
Organon (OGN) United States $2.259B 2.40
Ardent Health Partners (ARDT) United States $2.091B 8.91
GeneDx Holdings (WGS) United States $2.043B 78.68
Premier (PINC) United States $1.899B 14.41
Progyny (PGNY) United States $1.759B 38.72
PACS (PACS) United States $1.497B 0.00
GoodRx Holdings (GDRX) United States $1.336B 26.71
Teladoc Health (TDOC) United States $1.195B 0.00
Pediatrix Medical (MD) United States $1.165B 8.86
Establishment Labs Holdings (ESTA) $1.059B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
CareDx (CDNA) United States $0.944B 14.74
Agilon Health (AGL) United States $0.919B 0.00
Nutex Health (NUTX) United States $0.890B 13.45
AMN Healthcare Services Inc (AMN) United States $0.795B 7.44
QDM (QDMI) Hong Kong, SAR China $0.743B 0.00
Embecta (EMBC) United States $0.626B 4.22
InnovAge Holding (INNV) United States $0.531B 0.00
LifeMD (LFMD) United States $0.524B 0.00
Enhabit (EHAB) United States $0.518B 42.58
Auna S.A (AUNA) Luxembourg $0.492B 11.08
SBC Medicals (SBC) United States $0.471B 0.00
Sonida Senior Living (SNDA) United States $0.462B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.408B 0.00
Oncology Institute (TOI) United States $0.269B 0.00
Performant Healthcare (PHLT) United States $0.215B 0.00
Beauty Health (SKIN) United States $0.203B 0.00
KindlyMD (KDLY) United States $0.150B 0.00
DocGo (DCGO) United States $0.137B 22.33
OncoCyte (OCX) United States $0.096B 0.00
So-Young (SY) China $0.087B 0.00
Sera Prognostics (SERA) United States $0.066B 0.00
Ascend Wellness Holdings (AAWH) United States $0.061B 0.00
NeueHealth (NEUE) United States $0.060B 0.00
IceCure Medical (ICCM) Israel $0.059B 0.00
Biodesix (BDSX) United States $0.050B 0.00
Pheton Holdings (PTHL) China $0.043B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.031B 0.00
Basel Medical Group (BMGL) Singapore $0.025B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
ModivCare (MODV) United States $0.013B 0.00
Intelligent Bio Solutions (INBS) United States $0.010B 0.00
Co-Diagnostics (CODX) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00